Apparent partial loss of CD123 expression in blastic plasmacytoid dendritic cell neoplasm after treatment with CD123-targeted therapy: A novel finding and possible diagnostic pitfall.
Leomar Y BallesterNaveen PemmarajuCarlos A Torres-CabalaMadeleine DuvicMarina KonoplevaJoseph D KhouryVictor G PrietoPublished in: The Journal of dermatology (2020)